LifeTech Scientific Corporation (HKG:1302)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.120
+0.040 (1.92%)
Apr 29, 2026, 4:08 PM HKT
47.22%
Market Cap 9.63B
Revenue (ttm) 1.52B
Net Income (ttm) 164.50M
Shares Out 4.63B
EPS (ttm) 0.04
PE Ratio 56.64
Forward PE 18.15
Dividend n/a
Ex-Dividend Date n/a
Volume 30,588,000
Average Volume 30,532,257
Open 2.090
Previous Close 2.080
Day's Range 2.040 - 2.120
52-Week Range 1.410 - 2.440
Beta 0.28
RSI 68.99
Earnings Date Mar 31, 2026

About LifeTech Scientific

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. The company’s products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1999
Employees 1,240
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1302
Full Company Profile

Financial Performance

In 2025, LifeTech Scientific's revenue was 1.37 billion, an increase of 5.07% compared to the previous year's 1.30 billion. Earnings were 147.83 million, a decrease of -33.53%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.